Search details
1.
CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer.
Br J Cancer
; 128(2): 331-341, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36385556
2.
The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models.
Int J Mol Sci
; 22(4)2021 Feb 13.
Article
in English
| MEDLINE | ID: mdl-33668642
3.
Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples.
J Clin Pathol
; 76(10): 671-677, 2023 Oct.
Article
in English
| MEDLINE | ID: mdl-35701142
4.
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study.
J Pers Med
; 13(2)2023 Jan 25.
Article
in English
| MEDLINE | ID: mdl-36836440
5.
PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Cancer Cytopathol
; 128(3): 177-189, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31821747
Results
1 -
5
de 5
1
Next >
>>